Navigation Links
Pro-Dex, Inc. Announces Fiscal Second Quarter and Six Month Results
Date:2/10/2011

ense

775,000

641,000General and administrative expenses

1,660,000

1,526,000Impairment of intangible asset

-

140,000Research and development costs

1,196,000

1,197,000Total operating expenses

3,631,000

3,504,000Income from operations

977,000

369,000Other income (expense): Royalty income

-

3,000Interest expense

(80,000)

(103,000)Total other income (expense)

(80,000)

(100,000)Income before provision (benefit) for income taxes

897,000

269,000Provision (benefit) for income taxes

154,000

(494,000)Net income

$
743,000

$
763,000Net income (loss) per share:Basic

$
.23

$
.24Diluted

$
.23

$
.24Weighted average shares outstanding - basic

3,257,643

3,222,890Weighted average shares outstanding - diluted

3,263,654

3,228,777PRO-DEX, INC. and SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWSFor The Six Months Ended December 31, (unaudited)2010

2009Cash flows from operating activities: Net income

$
743,000

$
763,000Adjustments to reconcile net income to net cash provided by operating activities:Depreciation and amortization

342,000

371,000Impairment of intangible asset

-

140,000(Decrease) increase in allowance for doubtful accounts

(10,000)

5,000Stock based compensation

12,000

71,000Decrease in deferred taxes

-

(525,000)Changes in:Decrease in accounts receivable and other current receivables

148,000

226,000(Increase) decrease in inventories

(678,000)

148,000(Increase) in prepaid expenses

(30,000)

(185,000)Decrease in other assets

17,000

-(Decrease) in accounts payable and accrued expenses

(597,000)

(68,000)(Decrease) increase in income taxes payable

(5,000)


'/>"/>
SOURCE Pro-Dex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Pro-Dex, Inc. Appoints Harold A. Hurwitz as Chief Financial Officer
2. Pro-Dex, Inc. Announces Fiscal 2010 Third Quarter Financial Results Conference Call and Webcast
3. Pro-Dex, Inc. Announces Fiscal Second Quarter 2010 Results
4. Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customers Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders
5. PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement
6. Optimer Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
7. ThermoGenesis Announces Agreement for AXP and BioArchive Cord Blood Systems With Major Chinese Stem Cell Company
8. Perrigo Announces Settlement of Rogaine® Foam Patent Litigation
9. Awarepoint Announces First Annual RTLS Customer Conference and User Group Results and Highlights
10. Omeros Announces Publication of Data From Antifibrinolytic Program
11. Watson Announces Favorable District Court Ruling in Generic Mucinex® Patent Suit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 30, 2015 Oramed Pharmaceuticals Inc. ... pharmaceutical Company focused on the development of oral drug ... been screened in the Company,s Phase IIb trial of ... will be performed under the active Investigational New Drug ... Drug Administration (FDA). The Phase IIb study ...
(Date:6/30/2015)... , June 30, 2015  July 4 th ... of independence, and the spirit and people behind it. To ... has partnered with USA Medical Card, ... increase funding for programs that empower independence for our disabled ... and help more people afford their prescriptions. "Due ...
(Date:6/30/2015)... June 30, 2015  EnteroMedics Inc. (NASDAQ: ETRM ... neuroblocking technology to treat obesity, metabolic diseases, and other ... public offering  of 40,229,886 units. Each unit consists of ... A warrant to purchase one share of common stock, ... one share of common stock, at a purchase price ...
Breaking Medicine Technology:Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 2Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 3Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 3
... 3 Australian researchers have developed gene expression ... colorectal growths from non-cancerous controls. , , ... conference in Chicago, the preliminary findings are the ... Flinders University and Australian healthcare company, Clinical Genomics ...
... Day 3 And All Subsequent Study Visits - , ... Pharma Co., Ltd., (DSP) announced today that positive results from ... of patients with schizophrenia have been published in The ... placebo-controlled trial, involving 180 patients with acute schizophrenia, evaluated a ...
Cached Medicine Technology:Advance in Bowel Cancer Test Research 2Study Demonstrating Lurasidone Is Effective in Patients With Schizophrenia Published in The Journal of Clinical Psychiatry 2Study Demonstrating Lurasidone Is Effective in Patients With Schizophrenia Published in The Journal of Clinical Psychiatry 3Study Demonstrating Lurasidone Is Effective in Patients With Schizophrenia Published in The Journal of Clinical Psychiatry 4
(Date:7/1/2015)... (PRWEB) , ... July 01, ... ... in the communities of southeast Alabama, southwest Georgia and the Florida Panhandle, ... TelmedIQ as its primary secure text messaging and clinical communications workflow solution ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... the legal medical cannabis space, created a web-based resource where legal cannabis ... Harvest Financial brings together visionary entrepreneurs and medical marijuana advocates looking to strategically ...
(Date:7/1/2015)... ... ... Effective June 9, 2015, the Radiology Business Management Association (RBMA) ... process has been in place since the RBMA was founded in 1968 with all ... succeeds Keith E. Chew, MHA, CMPE, as president. Ms. Taylor has been an RBMA ...
(Date:6/30/2015)... , ... July 01, 2015 , ... Carey Danis ... lawsuits being managed in a West Virginia federal court. The court document outlined ... trial date for the 26 cases.¹ , Carey Danis & Lowe is a personal ...
(Date:6/30/2015)... ... ... Down is a reputable source of authentic Kid Rock tickets at the DTE Energy ... road again this summer in what is one of the most affordable summer tours in ... this year at the XFINITY Theatre in Hartford, CT on June 24th and the blockbuster ...
Breaking Medicine News(10 mins):Health News:Southeast Alabama Community Health System Chooses TelmedIQ to Meet Secure Text Messaging Challenges for Healthcare 2Health News:First Harvest Financial Partners in Launch of Legal Medical Cannabis Documentary Initiative 2Health News:First Harvest Financial Partners in Launch of Legal Medical Cannabis Documentary Initiative 3Health News:Radiology Business Management Association Announces Board of Directors and Officers for 2015-2016 2Health News:Radiology Business Management Association Announces Board of Directors and Officers for 2015-2016 3Health News:Radiology Business Management Association Announces Board of Directors and Officers for 2015-2016 4Health News:Carey Danis & Lowe Comments on New Pretrial Order in Vaginal Mesh Lawsuit 2Health News:Carey Danis & Lowe Comments on New Pretrial Order in Vaginal Mesh Lawsuit 3Health News:Cheap Kid Rock Tickets at the DTE Energy Music Theatre in Clarkston: Ticket Down Has Slashed Prices On All Kid Rock Tickets at DTE in the Detroit Metro Area 2
... 2,000,000 Minnesotans have designated their wishes to donate,on their ... April 1, 2008 When,Minnesotans apply for or renew ... with the opportunity to check the,box designating themselves organ ... taken that important step and said yes to the,life-saving ...
... CA, April 1, 2008 Rap music has gone from ... substance abuse to one that often glorifies illegal drug use, ... genre covering nearly two decades. The study is published ... a peer reviewed scientific journal., Positive portrayals of drug use ...
... protein helps virus conceal itself from body,s defenses , , ... discovered how HIV -- the virus that causes AIDS -- ... body,s immune cells. , They explained that when a normal ... immune system responds and produces cells that quickly eliminate the ...
... With Melanin-Rich Skin Tones, SKILLMAN, N.J., April 1, 2008 ... skin tones between,the ages of 25 and 54 experience dry ... only skin concern for these women. Women with,richer skin tones ... due to the excess melanin in their skin that often ...
... NEW YORK, April 1 SpongeTech Delivery,Systems, Inc. ... Darryl,Strawberry Foundation are pleased to announce corporate involvement ... for the New,York Mets, I am excited about ... have been a great tool for children with,autism, ...
... April 1, 2008 Valensa International,introduced Crannose(TM) ... Natural Products Expo West Conference. This patent-pending,supplement, ... known benefits of cranberry with D-mannose, a ... Larch tree. The,product is available in bulk, ...
Cached Medicine News:Health News:Minnesotans Demonstrate Commitment to Organ and Tissue Donation 2Health News:Drug use increasingly glamorized in rap music, according to new study of 2-decade trends 2Health News:Drug use increasingly glamorized in rap music, according to new study of 2-decade trends 3Health News:Scientists Uncover How HIV Hides Inside Cells 2Health News:AMBI(R) Introduces SOFT & EVEN(TM) 2Health News:AMBI(R) Introduces SOFT & EVEN(TM) 3Health News:SpongeTech Delivery Systems, Inc. to Donate to The Darryl Strawberry Foundation!! 2Health News:Crannose(TM) Extra Strength Women's Health Formula Targets Urinary Tract Infections 2
Used for internal biliary drainage. Supplied sterile in peel-open packages. Intended for one-time use....
... Marker directly to the biopsy site helps ... performed. ,The MICROMARK® II Tissue Marker is ... for use with the MAMMOTOME Biopsy System. ... site after a biopsy with the MAMMOTOME ...
... wrap than VICRYL knitted mesh. Especially suitable ... contained. Predictable absorption. Polyglactin 910 has been ... ,VICRYL (polyglactin 910) woven mesh is prepared ... and lactide, derived respectively from glycolic and ...
Used for implantation to reinforce soft tissue. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: